Michael Cherny
Stock Analyst at Leerink Partners
(0)
# 3991
Out of 5,240 analysts
150
Total ratings
50.00%
Success rate
-4.46%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Accolade | Downgrades: Market Perform | n/a | n/a | n/a | 8 | Jan 8, 2025 | |
McKesson | Maintains: Buy | 680 650 | 594.02 | 9.42% | 8 | Jan 6, 2025 | |
Align Tech | Upgrades: Outperform | 235 280 | 210.51 | 33.01% | 2 | Jan 6, 2025 | |
Quest Diagnostics | Upgrades: Outperform | 135 174 | 152.81 | 13.87% | 2 | Jan 6, 2025 | |
Cardinal Health | Upgrades: Buy | 132 145 | 123.98 | 16.95% | 7 | Jan 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 69 84 | 71.25 | 17.89% | 2 | Jan 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 29 32 | 30.89 | 1.49% | 18 | Dec 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 260 248 | 198.04 | 25.23% | 2 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 270 255 | 200.34 | 27.28% | 3 | Nov 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 21 | 20.08 | 4.58% | 9 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 7 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | 16 23 | 18.86 | 21.95% | 10 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 25 | 26.19 | -4.54% | 9 | Oct 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 277 275 | 240.33 | 14.43% | 3 | Oct 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 17 15 | n/a | n/a | 5 | Aug 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 95 77 | 51.58 | 49.28% | 10 | May 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 2.31 | 982.25% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 23 22 | 12.26 | 79.45% | 2 | Mar 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 260 | 234.56 | 10.85% | 1 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 23 | 21.47 | 4.8% | 4 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 4.13 | 93.7% | 5 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 32 | 50.67 | -36.85% | 1 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 19 | 10.76 | 76.58% | 1 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 17 | 9.35 | 81.82% | 1 | Feb 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 195 200 | n/a | n/a | 13 | Jun 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 2 | n/a | n/a | 1 | Nov 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 5 | n/a | n/a | 1 | Jan 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 113 53 | 14.07 | 273.13% | 2 | Jan 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 3000 | 2.76 | 108595.65% | 1 | Nov 23, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | n/a | n/a | 1 | Jul 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | n/a | n/a | 1 | Mar 8, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 4 | Jan 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 17 | n/a | n/a | 4 | Nov 25, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 51 | n/a | n/a | 1 | Aug 19, 2020 |